Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Balmer

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Vaccine|June 5, 2018
Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adultsJohannes Beeslaar, Judith Absalon, Paul Balmer, et al.
Infectious Diseases and Therapy|July 19, 2020
Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial DataJohannes Beeslaar, Paula Peyrani, Judith Absalon, et al.
Advances in Therapy|February 12, 2013
The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature reviewTin Tin Htar Myint, Harish Madhava, Paul Balmer, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in EnglandCaroline Trotter, Jamie Findlow, Paul Balmer, et al.
The Pediatric Infectious Disease Journal|April 14, 2011
Immunoglobulin G deficiency in United kingdom children with invasive pneumococcal diseaseElaine Stanford, Shamez Ladhani, Ray Borrow, et al.
Vaccine|March 23, 2005
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school childrenJamie Findlow, Ann Lowe, Sarah Deane, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccinePaul Balmer, Ray Borrow, Jamie Findlow, et al.
Infection and Immunity|September 10, 2008
Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal diseaseRay Borrow, Elaine Stanford, Pauline Waight, et al.
Human Vaccines & Immunotherapeutics|March 16, 2018
Vaccination strategies for the prevention of meningococcal diseaseScott Vuocolo, Paul Balmer, William C Gruber, et al.
Clinical and Vaccine Immunology : CVI|April 11, 2006
Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccineHelen Findlow, Jo Southern, Lesley Mabey, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Vaccine|June 5, 2018
Clinical data supporting a 2-dose schedule of MenB-FHbp, a bivalent meningococcal serogroup B vaccine, in adolescents and young adultsJohannes Beeslaar, Judith Absalon, Paul Balmer, et al.
Infectious Diseases and Therapy|July 19, 2020
Sex, Age, and Race Effects on Immunogenicity of MenB-FHbp, A Bivalent Meningococcal B Vaccine: Pooled Evaluation of Clinical Trial DataJohannes Beeslaar, Paula Peyrani, Judith Absalon, et al.
Advances in Therapy|February 12, 2013
The impact of 7-valent pneumococcal conjugate vaccine on invasive pneumococcal disease: a literature reviewTin Tin Htar Myint, Harish Madhava, Paul Balmer, et al.
Clinical and Vaccine Immunology : CVI|May 15, 2007
Seroprevalence of bactericidal and anti-outer membrane vesicle antibodies to Neisseria meningitidis group B in EnglandCaroline Trotter, Jamie Findlow, Paul Balmer, et al.
The Pediatric Infectious Disease Journal|April 14, 2011
Immunoglobulin G deficiency in United kingdom children with invasive pneumococcal diseaseElaine Stanford, Shamez Ladhani, Ray Borrow, et al.
Vaccine|March 23, 2005
Effect of sequence variation in meningococcal PorA outer membrane protein on the effectiveness of a hexavalent PorA outer membrane vesicle vaccine in toddlers and school childrenJamie Findlow, Ann Lowe, Sarah Deane, et al.
Clinical and Vaccine Immunology : CVI|September 21, 2007
Age-stratified prevalences of pneumococcal-serotype-specific immunoglobulin G in England and their relationship to the serotype-specific incidence of invasive pneumococcal disease prior to the introduction of the pneumococcal 7-valent conjugate vaccinePaul Balmer, Ray Borrow, Jamie Findlow, et al.
Infection and Immunity|September 10, 2008
Serotype-specific immune unresponsiveness to pneumococcal conjugate vaccine following invasive pneumococcal diseaseRay Borrow, Elaine Stanford, Pauline Waight, et al.
Human Vaccines & Immunotherapeutics|March 16, 2018
Vaccination strategies for the prevention of meningococcal diseaseScott Vuocolo, Paul Balmer, William C Gruber, et al.
Clinical and Vaccine Immunology : CVI|April 11, 2006
Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccineHelen Findlow, Jo Southern, Lesley Mabey, et al.
Pageof 8